Principle
COVID-19 Antigen Detection Test is an immunoassay take a look at for fast and qualitative detection of SARS-CoV-2 an infection from swab specimens. Monoclonal anti-SARS-CoV-2 antibodies are coated on the take a look at line area. Antigens of SARS-CoV-2, if current within the specimens will work together with monoclonal antiSARS-CoV-2 antibodies conjugated with gold conjugate making antigen-antibodies conjugate advanced. This advanced migrates on the membrane by capillary motion, the place will probably be captured by the monoclonal anti-SARS-CoV-2 antibody coated on the take a look at line. A coloured take a look at line can be seen within the consequence window if SARS-CoV-2 antigens are current within the specimen. The depth of coloured take a look at line will differ relying upon the quantity of SARS-CoV-2 antigen current within the specimen.
SKU:NCTCAG-01
AVAILABILITY:Sold Out
SHIPMENT:1 or 2 Working Days for Free
SIZE:25 Tests/Kit
SENSITIVITY:96.6%
SPECIFICITY:100%

meriscreen-covid-19-antigen-test-kit-pack
MERISCREEN COVID-19 ANTIGEN TEST KIT
MeriScreen COVID-19 Antigen Detection Test is a fast immunochromatographic assay take a look at for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal swab pattern from a human physique.
- COATED WITH HIGHLY PURIFIED MONOCLONAL ANTI-SARS-COV-2 ANTIBODY
- RESULTS IN 20 MINUTES
- SAMPLE IS NASOPHARYNGEAL SWAB
- SENSITIVITY: 96.6%
- SPECIFICITY: 100%
Please Note:
Below listed kits are validated with the talked about batch quantity solely. Responsibility for batch to batch
consistency doesn’t lies with ICMR.
Minimum acceptance standards of sensitivity and specificity of Rapid Ag Test Kits:
Validated as a Point of Care Test (POCT) with out transport to a laboratory setupSensitivity: 50% and above
Specificity: 95% and above
Validated in a laboratory setup with samples collected in Viral Transport Medium (VTM)-
Sensitivity: 70% and above
Specificity: 99% and above
Antigen based mostly fast assessments that are US-FDA authorized can be utilized straight after due advertising and marketing approval from DCGI.
Brief methodology of use of COVID-19 Ag Respi-Strip (CorisBioConcept):
1. The Nasopharyngeal and/or Oropharyngeal swab will probably be collected from COVID-19 suspect affected person in Viral Transport Medium (VTM).
2. The collected swab in VTM will probably be delivered to the laboratory in acceptable chilly chain situations.
3. Once the pattern is delivered to the laboratory, it’s going to should be dealt with in a BSL-2 stage cupboard for aliquoting, placing in lysis buffer and loading the take a look at strip.
Steps 1 & 2 will probably be carried out as per the usual apply adopted for assortment and transport of samples for COVID-19 RT-PCR take a look at.
Step Three will should be carried out as per producers’ directions given with the take a look at equipment.

meriscreen-covid-19-antigen-test-kit
Easy to Use
User-friendly interface; Requires no particular experience or in depth coaching.
High Accuracy and Reliability
Excellent sensitivity and specifimetropolis in comparison with molecular and viral tradition strategies.
Convenient Storage Options
Small instrument dimension and room-temp storage appropriate for any workplace or lab.
Reduced User Errors
QR code scanning robotically identifies the take a look at kind
Dual Testing Options
Dual testing choices permit for higher testing flexibility
![]() CA199 (Cancer antigen) ELISA test |
|||
13 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen) |
![]() CEA (Cancer antigen) ELISA test |
|||
9 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of CEA (Cancer antigen) |
![]() CA125 (Cancer antigen) ELISA test |
|||
11 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen) |
![]() PSA (Prostate-specific antigen) ELISA test |
|||
8 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen) |
![]() HBsAg hepatitis B surface antigen ELISA test |
|||
77 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of HBsAg hepatitis B surface antigen |
![]() HBeAg hepatitis B E antigen ELISA test |
|||
79 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of HBeAg hepatitis B E antigen |
![]() HEV-Ag hepatitis E antigen ELISA test |
|||
94 | Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of HEV-Ag hepatitis E antigen |
![]() SARS-CoV-2 Antigen Rapid Test Kit |
|||
CoV2Ag-1 | UnScience | 1T | EUR 8 |
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
![]() SARS-CoV-2 Antigen Rapid Test Kit |
|||
CoV2Ag-25 | UnScience | 25T/kit | EUR 35 |
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
![]() SARS-CoV-2 Rapid Antigen Test Nasal |
|||
9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 94 |
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
![]() Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit |
|||
abx092096-20tests | Abbexa | 20 tests | EUR 398 |
![]() Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092015-40tests | Abbexa | 40 tests | EUR 432 |
![]() Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092016-40tests | Abbexa | 40 tests | EUR 432 |
![]() Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092049-20tests | Abbexa | 20 tests | EUR 230 |
![]() Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | EUR 39 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
![]() Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | EUR 236 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
![]() Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-40tests | Accu test | 40 tests | EUR 321 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
![]() Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092014-40tests | Abbexa | 40 tests | EUR 488 |
![]() Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092017-40tests | Abbexa | 40 tests | EUR 432 |
![]() DNASE TEST AGAR |
|||
D04-101-10kg | Alphabiosciences | 10 kg | Ask for price |
![]() DNASE TEST AGAR |
|||
D04-101-2Kg | Alphabiosciences | 2 Kg | Ask for price |
![]() DNASE TEST AGAR |
|||
D04-101-500g | Alphabiosciences | 500 g | Ask for price |
![]() DERMATOPHYTE TEST AGAR |
|||
D04-107-10kg | Alphabiosciences | 10 kg | EUR 849 |
![]() DERMATOPHYTE TEST AGAR |
|||
D04-107-2Kg | Alphabiosciences | 2 Kg | EUR 224 |